fluoxymesterone has been researched along with Hematologic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, S; Bosworth, H; Budman, D; Lehrman, D; Lichtman, SM; Schulman, P; Vinciguerra, V; Weiselberg, L; Weiss, R | 1 |
| Longson, D | 1 |
1 review(s) available for fluoxymesterone and Hematologic Diseases
| Article | Year |
|---|---|
Androgen therapy.
Topics: Anabolic Agents; Androgens; Androstanes; Breast Neoplasms; Climacteric; Female; Fluoxymesterone; Hematologic Diseases; Humans; Hypopituitarism; Male; Methyltestosterone; Testicular Diseases; Testis; Testosterone | 1972 |
1 other study(ies) available for fluoxymesterone and Hematologic Diseases
| Article | Year |
|---|---|
Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esthetics; Female; Fluorouracil; Fluoxymesterone; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prednisone; Radiotherapy; Survival Rate; Thiotepa; Vinblastine; Vincristine | 1991 |